Drug Type Small molecule drug |
Synonyms (-)-DDMS, (-)-didesmethylsibutramine, (S)-didesmethylsibutramine + [5] |
Action antagonists |
Mechanism Dopamine reuptake inhibitors, adrenergic receptor antagonists(Adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC15H22ClN |
InChIKeyWQSACWZKKZPCHN-AWEZNQCLSA-N |
CAS Registry229639-57-0 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | (-)-Desmethylsibutramine | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Erectile Dysfunction | Phase 2 | - | - | |
| Male sexual dysfunction | Phase 2 | United States | - | - |
| Female sexual dysfunction | Phase 1 | United States | - | - |
| Urinary Incontinence, Stress | Phase 1 | - | - |





